| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jul 05, 2022 | Jul 07, 2022 | Prasad Suyash CMO Head of R D | Sell | Taysha Gene Therapies, Inc. | TSHA | $3.7 | $47,650 | -2.37% |
| Jun 29, 2022 | Jul 01, 2022 | Prasad Suyash CMO Head of R D | Sell | Taysha Gene Therapies, Inc. | TSHA | $3.65 | $183,081 | -8.45% |
| Jun 29, 2021 | Jul 01, 2021 | Prasad Suyash CMO Head of R D | Sell | Taysha Gene Therapies, Inc. | TSHA | $22.63 | $2M | -11.75% |
| May 13, 2019 | May 15, 2019 | Prasad Suyash SVP Chief Med Officer | Sell | Audentes Therapeutics, Inc. | BOLD | $36.98 | $369,798 | -35.42% |
| Feb 25, 2019 | Feb 27, 2019 | Prasad Suyash SVP Chief Med Officer | Sell | Audentes Therapeutics, Inc. | BOLD | $30.06 | $300,553 | -35.42% |
| Oct 01, 2018 | Oct 02, 2018 | Prasad Suyash SVP Chief Med Officer | Sell | Audentes Therapeutics, Inc. | BOLD | $36.88 | $368,788 | -68.03% |
| Jul 02, 2018 | Jul 05, 2018 | Prasad Suyash SVP Chief Med Officer | Sell | Audentes Therapeutics, Inc. | BOLD | $38.41 | $384,067 | -66.62% |
| Mar 29, 2017 | Mar 30, 2018 | Prasad Suyash SVP Chief Med Officer | Sell | Audentes Therapeutics, Inc. | BOLD | $30.03 | $234,195 | -0 |
| Mar 26, 2018 | Mar 29, 2018 | Prasad Suyash SVP Chief Med Officer | Sell | Audentes Therapeutics, Inc. | BOLD | $30 | $66,000 | -0 |
| Dec 01, 2017 | Dec 05, 2017 | Prasad Suyash SVP Chief Med Officer | Sell | Audentes Therapeutics, Inc. | BOLD | $28.53 | $228,264 | -0 |
| Sep 01, 2017 | Sep 01, 2017 | Prasad Suyash SVP Chief Med Officer | Sell | Audentes Therapeutics, Inc. | BOLD | $21.44 | $171,481 | -0 |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.